As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's rapid-growth life sciences division. Previously, Guillen served as a Board ...

This approval positions Lupin to tap into a substantial market opportunity for a drug indicated for the treatment of ...

Friday's optimism in Wall Street brought cheer to the Nifty and Sensex in the Monday morning trade, as bulls took over the ...

TAIPEI, March 18, 2025 /PRNewswire/ -- TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a ...

Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5 ...

Indian stock markets surged as auto, financial, and banking sector stocks led the rally on Dalal Street. Nifty Pharma gained ...

The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

Domestic stock indices saw minor gains on Monday, buoyed by receding fears of a US government shutdown and anticipation of the US Federal Reserve's upcoming policy review. The Nifty closed just above ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

In a world where millions lack access to quality prosthetics, India is leading the way with indigenous, world-class solutions ...